Concepedia

Abbas Nazir

AN

6

Publications

543

Citations

6

H-Index

2016

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Agios Pharmaceuticals (United States)

Abbas Nazir is an author at Memorial Sloan Kettering Cancer Center specializing in genetics, medicine, and molecular biology.

ORCID

Top concepts

Publications per year

2016–2024

6

Publications

6

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Andrew M. Intlekofer, Alan H. Shih, Bo Wang et al. · Nature · 2018 · 271 citations · Full text

, , +8

Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i> - and <i>TET2</i> -Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank et al. · Cancer Discovery · 2017 · 110 citations · Full text

Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity

Hiroyoshi Kunimoto, Cem Meydan, Abbas Nazir et al. · Cancer Cell · 2017 · 100 citations · Full text

, , +11

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Andrew Dunbar, Robert L. Bowman, Young C. Park et al. · Cancer Discovery · 2024 · 27 citations · Full text

Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells

Hiroyoshi Kunimoto, Anna Sophia McKenney, Cem Meydan et al. · Blood · 2017 · 22 citations · Full text

Rows per page

1–5 of 6